Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bialek-Gosk (Warszawa, Poland), M. Dabrowska (Warszawa, Poland), E. Grabczak (Warszawa, Poland), O. Truba (Warszawa, Poland), A. Rybka-Fraczek (Warszawa, Poland), K. Klimowicz (Warszawa, Poland), R. Krenke (Warszawa, Poland). Response to inhaled corticosteroids in patients with non-asthmatic eosinophilic bronchitis. 987

Member's Comments

No comment yet.

Related content which might interest you: The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis Source: Eur Respir J 2008; 32: 1119-1122 Year: 2008 Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002 Exacerbations and inhaled corticosteroids in bronchiectasis patients Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids Source: Annual Congress 2003 - Current issues on wheezing in infancy Year: 2003 Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Montelukast plus inhaled budesonide versus double dose inhaled budesonide in nonasthmatic eosinophilic bronchitis Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Risks of pneumonia in asthmatic patients taking inhaled corticosteroids Source: Annual Congress 2010 - Management of airway disease Year: 2010 Reduction of inhaled corticosteroids in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007 Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 Intranasal and inhaled corticosteroids in allergic rhinitis and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Obesity and the response to inhaled budesonide in patients with asthma Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Risk of bronchiectasis in bronchial asthma: steroid-dependent versus non-steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005 Evaluation of bronchial hyperreactivity and hypersensitivity in asthmatics and bronchitis patients Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Use of budesonide suspension during the exacerbation of severe steroid-dependent bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Nebulized therapy in bronchial asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002